Skip to main content
SHC logo

SHC · Sotera Health Co · Webcasts, Transcripts & Audio

Track SHC — free
Market Cap
$4.74B
Shares
285.63M
Volume · Nov 13 2.65M Avg daily vol (3M) 2.3M

Sotera Health Co Webcasts

Earnings calls, investor updates, investor days and conferences for Sotera Health Co (SHC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-12-02
Sotera Health Co (SHC) December 2, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-18
Sotera Health Co (SHC) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-11-03
Sotera Health Co (SHC) Q3 2026 Earnings Call Transcript
Positive tone Nelson Labs growth and project mix Sterigenics performance and pricing 2026 financial outlook
Revenue
$324.89M
▲ 4.4% YoY
Diluted EPS
$0.20
▲ 17.6% YoY
Gross margin
55.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-09
Sotera Health Co (SHC) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Sotera Health Co (SHC) Q2 2026 Earnings Call Transcript
Confident tone Segment performance and constant currency growth New CEO transition and leadership Ethylene oxide (EO) litigation
Revenue
$321.38M
▲ 9.2% YoY
Diluted EPS
$0.19
▲ 533.3% YoY
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Sotera Health Co (SHC) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Sotera Health Co (SHC) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-19
Sotera Health Co (SHC) May 19, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Sotera Health Co (SHC) Q1 2026 Earnings Call Transcript
Confident tone Sterigenics segment performance Nelson Labs softness Georgia ethylene oxide bellwether litigation dismissals
Revenue
$280.05M
▲ 10% YoY
Diluted EPS
$0.09
Gross margin
52.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Sotera Health Co (SHC) Q4 2025 Earnings Call Transcript
Confident tone Sterigenics segment performance Long-range plan execution and 2026 outlook Nelson Labs
Revenue
$303.44M*
▲ 4.6% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Sotera Health Co (SHC) Q3 2025 Earnings Call Transcript
Confident tone Sterigenics performance 2025 guidance Nelson Labs turnaround
Revenue
$311.31M
▲ 9.1% YoY
Diluted EPS
$0.17
▲ 183.3% YoY
Gross margin
57.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Sotera Health Co (SHC) Q2 2025 Earnings Call Transcript
Confident tone Sterigenics growth and volume recovery Nelson Labs margin expansion End market normalization / destocking
Revenue
$294.34M
▲ 6.4% YoY
Diluted EPS
$0.03
▲ 0% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Sotera Health Co (SHC) Q1 2025 Earnings Call Transcript
Confident tone Segment performance and growth Sterigenics pricing 2025 guidance and outlook
Revenue
$254.52M
▲ 2.6% YoY
Diluted EPS
$-0.05
▼ 350% YoY
Gross margin
53.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Sotera Health Co (SHC) Q4 2024 Earnings Call Transcript
Positive tone Revenue and EBITDA growth Nordion / cobalt-60 harvest timing Tariff exposure and risk
Revenue
$290.20M*
▼ 6.5% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Sotera Health Co (SHC) Q3 2024 Earnings Call Transcript
Positive tone Sterigenics segment performance Continuous glucose monitors / integrated solutions Nelson Labs performance
Revenue
$285.47M
▲ 8.5% YoY
Diluted EPS
$0.06
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Sotera Health Co (SHC) Q2 2024 Earnings Call Transcript
Positive tone Nordion Segment Sterigenics Segment Nelson Labs Segment
Revenue
$276.59M
▲ 8.3% YoY
Diluted EPS
$0.03
▼ 62.5% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Sotera Health Co (SHC) Q1 2024 Earnings Call Transcript
Positive tone Financial Results Sterigenics Segment Ethylene Oxide Litigation
Revenue
$248.18M
▲ 12.5% YoY
Diluted EPS
$0.02
▲ 100% YoY
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Sotera Health Co (SHC) Q4 2023 Earnings Call Transcript
Positive tone Nordion / Cobalt-60 Liquidity and leverage Revenue and EBITDA growth
Revenue
$310.24M*
▲ 23.3% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Sotera Health Co (SHC) Q3 2023 Earnings Call Transcript
Revenue
$263.18M
▲ 5.8% YoY
Diluted EPS
$-0.05
▼ 155.6% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Sotera Health Co (SHC) Q2 2023 Earnings Call Transcript
Revenue
$255.28M
▼ 4.3% YoY
Diluted EPS
$0.08
▼ 27.3% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Sotera Health Co (SHC) Q1 2023 Earnings Call Transcript
Revenue
$220.59M
▼ 6.8% YoY
Diluted EPS
$0.01
▼ 90.9% YoY
Gross margin
50.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Sotera Health Co (SHC) Q4 2022 Earnings Call Transcript
Revenue
$251.59M*
▲ 4.3% YoY
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Sotera Health Co (SHC) Q3 2022 Earnings Call Transcript
Revenue
$248.70M
▲ 10% YoY
Diluted EPS
$0.09
▼ 10% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Sotera Health Co (SHC) Q2 2022 Earnings Call Transcript
Revenue
$266.64M
▲ 5.8% YoY
Diluted EPS
$0.11
▼ 26.7% YoY
Gross margin
56.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Sotera Health Co (SHC) Q1 2022 Earnings Call Transcript
Revenue
$236.75M
▲ 11.6% YoY
Diluted EPS
$0.11
▲ 175% YoY
Gross margin
54.4%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Sotera Health Co (SHC) Q4 2021 Earnings Call Transcript
Revenue
$241.25M*
▲ 11.3% YoY
Gross margin
55.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Sotera Health Co (SHC) Q3 2021 Earnings Call Transcript
Revenue
$226.16M
▲ 13.1% YoY
Diluted EPS
$0.10
Gross margin
55.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Sotera Health Co (SHC) Q2 2021 Earnings Call Transcript
Revenue
$251.92M
▲ 18.2% YoY
Diluted EPS
$0.15
▲ 400% YoY
Gross margin
57.1%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Sotera Health Co (SHC) Q1 2021 Earnings Call Transcript
Revenue
$212.15M
▲ 12.7% YoY
Diluted EPS
$0.04
Gross margin
54.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
Sotera Health Co (SHC) Q4 2020 Earnings Call
Revenue
$216.84M*
Gross margin
55.6%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 webcasts
Key facts CIK 1822479 CUSIP 83601L102 13F (30d) 256 filings 238 filers Visit website Investor relations